1. Choi W, Pai H, Kim K et al. Iron deficiency anemia increases nitric oxide production in healthy adolescents. Ann Hematol 2002; 81: 1–6.
2. Thomas S, Ellertson C et al. Nuisance or natural and healthy: should monthly Menstruation be optional for women? Lancet 2000; 355: 922–4.
3. Andrist L, Raquel D et al. Women’s and provides` attitudes towards menstrual suppression with extended use of oral contraceptives. Contraception 2004; 70: 359–63.
4. Tonkela I, Oddens B. Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use and HRT use. Contraception 1999; 59: 357–62.
5. Association of Reproductive Health Professionals. Choosing when to menstruate: the role of extended contraception Retrieved April 21, 2004 from http://arhp/healthcareproviders/visitingfacultyprograms/extended/nationalsurvey.cfm; 2002.
6. Sulak P, Scow R et al. Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol 2000; 95: 261–6.
7. Milan R Henzl, Polan Ml. Avoiding Menstruation. J Reprod Med 2003; 49 (3): 162–74.
8. Kistne RW. Use of new progestins in the treatment of endometriosis. Am J Obstet Gynecol 1956; 75: 264–78.
9. World Health Organization Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids. Norethindrone enanthate and medroxyprogesterone acetate. Final Report. Contraception 1983; 28: 1–20.
10. World Health Organization Task Force on long-acting systemic agents for fertility regulation: multicenter phase III comparative clinical trial of depot-MPA given three month at doses of 100 mg or 150 mg. Contraceptive efficacy and side effects. Contraception 1986; 34: 223–35.
11. Loudon NB, Fozwell M, Potta DM et al. Acceptability of an oral contraceptive that reduces the frequency of menstruation. The tri-cycle regiment. BMJ 1997; 2: 487–90.
12. Miller L, Notter KM. Menstrual reduction with extended use of combination oral contraceptive pills: randomized controlled trial. Obstet Gynecol 2001; 98: 771–8.
13. Kwiecien M, Edelman A, Nicols AMD et al. Bleeding patterns and patient acceptability of standard or continuous dosing regiments of low-dose oral contraceptive. A randomized trial. Contraception 2003; 67: 9–13.
14. de Voogd WS. Postponement of withdrawal bleeding with a monophasic oral contraceptive containing desogestrel and ethinilestradiol. Contraception 1991; 44: 107–12.
15. Strassman BI. The evolution of endometrial cycles and menstruation. Q Rev Biol 1996; 71: 181–220.
16. Cachrimanidou A, Hellberg D et al. Long interval treatment regiment with desogestrel-containing oral contraceptive. Contraception 1993; 48: 205–16.
17. Shakespeare J, Neve E, Hodder K. Is norethisterone a lifestyle drug? Results of database analysis. BMJ 2000; 320: 291–4.
18. O`Grady K. Is menstruation obsolete? http:||www.third-space.ca/articles/ogrady.htm
19. Loudon N, Foxwell M et al. Acceptability of an oral contraceptive that reduces the frequency of menstruation: the tri-cycle pill regiment. BMJ 1977; 35: 199–205.
20. Crook D. Cardiovascular implications of menstrual cycle irregularities. Gynecol Forum 2003; 8: 10–3.
21. Sulak P, Cressman B, Waldorp E et al. Extending the duration of active oral contraceptive pills to manage hormone Withdrawal symptoms Ob Gyn 1997; 89: 181–220.
22. Vircellini P, De Giorgio O et al. Cyproterone acetate versus a continuous oral monophasic contraceptives in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis. Fertil Steril 2002; 77: 52061.

Н.М.Подзолкова, И.В.Кузнецова, В.В.Коренная

Кафедра акушерства и гинекологии (зав. – проф. Н.М.Подзолкова) 
Российской медицинской академии последипломного образования, Москва